May 26th, 2022 - 17:00 CET
Genomic profiling in precision oncology is transforming cancer care for your patients.
But long waiting periods for biomarker test results from the lab can delay therapy decisions, with potential consequences for the patient’s outcomes.
Join us live on May 26, 2022 to hear about a new development in NGS biomarker testing which will enable a broad spectrum of laboratories to produce fast, clinically relevant biomarker data and enable clinicians to make timely therapy based on complete, relevant information.
In this webinar you will:
- Learn about a new NGS test for precision oncology biomarker testing based on an end-to-end NGS workflow solution which can deliver results in as little as 24 hours.
- Hear results of a multicentric study evaluating performance of the test in development.
- Hear, from oncologists’ point of view, about the importance of timely availability of all clinically relevant biomarker data for the therapy management and potentially clinical outcomes of the oncology patients
